Evaluation of the effectiveness of Ipecac homeopathic remedy in control of Clinical manifestations of COVID-19

Double blind clinical trial study on Evaluation of the effectiveness of Ipecac homeopathic remedy in control of Clinical manifestations of COVID-19

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140907019073N4

Enrollment

Registered

2020-03-29

Start date

2020-04-03

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

covid-19. Covid-19

Interventions

Intervention 1: The one globule of (Ipecac)homeopathy remedy with C30 potency produced by Hellios homeopathy pharmacy distilled in 20 ml. 10 degree alcohol which will be administered at a dose of 15

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Suspected or uncertain cases of patients admitted to one of Rasoul-e-Akram or Firoozgar Hospitals with a diagnosis of Covid19 (based on national Guideline).

Exclusion criteria

Exclusion criteria: Patients should not be intubated. Patient should not be immune defective.

Design outcomes

Primary

Measure	Time frame
Fever. Timepoint: The first day, the second day, the third day. Method of measurement: Check body temperature with thermometer.;Cough. Timepoint: The first day, the second day, the third day. Method of measurement: Physician report.;Shortness of breath. Timepoint: The first day, the second day, the third day. Method of measurement: Patient Report.;Chills. Timepoint: The first day, the second day, the third day. Method of measurement: Patient Report.;Myalgia. Timepoint: The first day, the second day, the third day. Method of measurement: Patient Report.;O2 arterial blood saturation. Timepoint: The first day, the second day, the third day. Method of measurement: Pulse Oximeter Report.;Number of lymphocytes. Timepoint: The first day, the second day, the third day. Method of measurement: Blood test.;Serum CRP. Timepoint: The first day, the second day, the third day. Method of measurement: Blood test.	—

Measure

Time frame

Fever. Timepoint: The first day, the second day, the third day. Method of measurement: Check body temperature with thermometer.;Cough. Timepoint: The first day, the second day, the third day. Method of measurement: Physician report.;Shortness of breath. Timepoint: The first day, the second day, the third day. Method of measurement: Patient Report.;Chills. Timepoint: The first day, the second day, the third day. Method of measurement: Patient Report.;Myalgia. Timepoint: The first day, the second day, the third day. Method of measurement: Patient Report.;O2 arterial blood saturation. Timepoint: The first day, the second day, the third day. Method of measurement: Pulse Oximeter Report.;Number of lymphocytes. Timepoint: The first day, the second day, the third day. Method of measurement: Blood test.;Serum CRP. Timepoint: The first day, the second day, the third day. Method of measurement: Blood test.

—

Secondary

Measure	Time frame
Need ventilator. Timepoint: The first day, the second day, the third day. Method of measurement: Physician diagnosis.;The amount of oxygen received. Timepoint: The first day, the second day, the third day. Method of measurement: Manometer view.;Oxygen Intake Method. Timepoint: The first day, the second day, the third day. Method of measurement: Observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarbod Rahnama Chitsaz

Medical Council of Iran

farbod.chitsaz@gmail.com+98 21 8413 0001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026